Wang Qian, Song Yuanyuan, Kim Mungu, Hahn Sei Kwang, Jiang Ge
Bioengineering College, Dalian University, 10 Xuefu Street, Jinzhou District, Dalian, 116600, Liaoning, China.
Department of Materials Science and Engineering, Pohang University of Science and Technology (POSTECH), 77 Cheongam-Ro, Nam-Gu, Pohang, 790-784, Gyeongbuk, Korea.
Biomater Res. 2023 Feb 17;27(1):13. doi: 10.1186/s40824-023-00351-4.
The main protease (Mpro) is a crucial target for severe acute respiratory syndrome coronavirus (SARS-CoV-2). Chitooligosaccharide (CS) has broad-spectrum antiviral activity and can effectively inhibit the activity of SARS-CoV. Here, based on the high homology between SARS-CoV-2 and SARS-CoV, this study explores the effect and mechanism of CS with various molecular weights on the activity of SARS-CoV-2 Mpro.
We used fluorescence resonance energy transfer (FRET), UV-Vis, synchronous fluorescence spectroscopy, circular dichroism (CD) spectroscopy and computational simulation to investigate the molecular interaction and the interaction mechanism between CS and SARS-CoV-2 Mpro.
Four kinds of CS with different molecular weights significantly inhibited the activity of Mpro by combining the hydrogen bonding and the salt bridge interaction to form a stable complex. Glu166 appeared to be the key amino acid. Among them, chitosan showed the highest inhibition effect on Mpro enzyme activity and the greatest impact on the spatial structure of protein. Chitosan would be one of the most potential anti-viral compounds.
This study provides the theoretical basis to develop targeted Mpro inhibitors for the screening and application of anti-novel coronavirus drugs.
主要蛋白酶(Mpro)是严重急性呼吸综合征冠状病毒(SARS-CoV-2)的关键靶点。壳寡糖(CS)具有广谱抗病毒活性,能有效抑制SARS-CoV的活性。在此,基于SARS-CoV-2与SARS-CoV之间的高度同源性,本研究探讨了不同分子量的CS对SARS-CoV-2 Mpro活性的影响及其作用机制。
我们采用荧光共振能量转移(FRET)、紫外可见光谱、同步荧光光谱、圆二色(CD)光谱和计算模拟等方法,研究CS与SARS-CoV-2 Mpro之间的分子相互作用及作用机制。
四种不同分子量的CS通过氢键和盐桥相互作用结合形成稳定复合物,显著抑制了Mpro的活性。Glu166似乎是关键氨基酸。其中,壳聚糖对Mpro酶活性的抑制作用最强,对蛋白质空间结构的影响最大。壳聚糖有望成为最具潜力的抗病毒化合物之一。
本研究为开发靶向Mpro抑制剂用于抗新型冠状病毒药物的筛选和应用提供了理论依据。